Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
نویسندگان
چکیده
BACKGROUND The American College of Physicians recommends perioperative use of beta-blockers for certain patients to improve outcomes after surgery. Study of physician behavior with respect to guidelines and recommended practices have shown that beta-blockers have been underutilized after myocardial infarction. We evaluated physician concordance with the perioperative use of beta-blockers along with a specialty-related difference in the frequency of perioperative beta-blocker use. METHODS To determine perioperative use of beta-blockers, we retrospectively analyzed the medical charts of adult patients who underwent open cholecystectomy at a tertiary care medical center from December 1997 through December 2001. Patients met criteria for perioperative beta-blocker use if they had a history of coronary artery disease or if they had the presence of 2 or more of the following risk factors: 65 years or older; history of hypertension, diabetes mellitus, or hypercholesterolemia; or current smoking. RESULTS Among the 336 cases of cholecystectomy reviewed, criteria for beta-blocker use were met in 146 patients (43%) who did not have emergency operations and/or contraindications to beta-blocker use. Of these 146 patients, 123 (84%) had a documented preoperative medical evaluation by a physician in the medical chart. There were 44 patients (30%) receiving beta-blockers prior to admission, and 102 patients (70%) were not receiving beta-blockers. Of those 102 patients not receiving beta-blockers at admission but who meet criteria for their use, 94 (92%) were not started on beta-blocker therapy preoperatively. Of the 18 patients evaluated by a cardiologist, 4 (22%) were started on beta-blocker therapy compared with 3 (6%) of 47 patients evaluated by a noncardiologist physician (P =.08). CONCLUSION Perioperative beta-blocker therapy is underutilized in patients with risk factors for coronary artery disease despite evidence that its use in appropriate individuals may be lifesaving.
منابع مشابه
Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.
BACKGROUND American College of Cardiology and American Heart Association (ACC/AHA) guidelines on perioperative assessment recommend perioperative beta blockers for non-cardiac surgery, although results of some clinical trials seem not to support this recommendation. We aimed to critically review the evidence to assess the use of perioperative beta blockers in patients having non-cardiac surgery...
متن کاملControversies in perioperative medicine.
Coexisting medical problems are common in surgical patients. Due to the lack of convincing studies, however, the optimal strategies for perioperative management of many medical problems remain unclear. Thus, practices are often based on inconclusive clinical studies or extrapolated from current understanding of pathophysiology. This article reviews guidelines and practices for endocarditis prop...
متن کاملUpdated guidelines on cardiovascular evaluation before noncardiac surgery: a view from the trenches.
In August 2014, the American College of Cardiology and American Heart Association updated their guidelines on cardiovascular evaluation and care before noncardiac surgery and simultaneously published a systematic review of perioperative use of beta-blockers. The update reinforces many previous recommendations and provides new evidence and expert opinion that is useful to the perioperative team.
متن کاملTHe PeRIOPeRaTIve use OF ß-BlOCkeRs
Perioperative myocardial infarction is a leading cause of postoperative morbidity and mortality (1). The etiology of postoperative MI is the subject of some debate but is thought to include prolonged ischemia resulting from tachycardia (2). Perıoperatıve blockade could prevent perioperative cardiac damage and improve long-term cardiac outcome in noncardiac surgical patients. The beneficial effe...
متن کاملACCF and AHA Release Guidelines on the Management of Heart Failure.
Treatment of stage A heart failure should focus on reducing modifiable risk factors, including management of hypertension and hyperlipidemia. To prevent symptomatic heart failure, ACE inhibitors and beta blockers should be used in all patients with stage B or C heart failure who have a reduced ejection fraction. Patients with stage C heart failure and fluid retention should be treated with diur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Archives of internal medicine
دوره 164 6 شماره
صفحات -
تاریخ انتشار 2004